|

Application of Improved Baduanjin Combined Cross-theoretical Model Based on Internet in Family Empowering Elderly PCI Cardiac Rehabilitation

RECRUITINGN/ASponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Actively Recruiting
PhaseN/A
SponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine
Started2024-12-01
Est. completion2025-07-31
Eligibility
Age60 Years – 75 Years
Healthy vol.Accepted

Summary

This study explores the effect of Internet based improved Baduanjin combined cross-theoretical model in family empowering cardiac rehabilitation for elderly patients with coronary heart disease after PCI, provides a scientific and reasonable case management plan for the rehabilitation of patients with coronary heart disease, and provides a reference for the development of scientific and refined cardiac rehabilitation case management suitable for elderly patients with PCI.

Eligibility

Age: 60 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* (1) All met the diagnostic criteria for coronary heart disease;
* (2) PCI was performed for the first time with clear indications of PCI surgery;
* (3) Postoperative condition was stable;
* (4) NYHA cardiac function grade I-II;
* (5) Age 60 \~75 years old;
* (6) Patients and their family members gave informed consent to this study and signed informed consent, which met the ethical standards of human trials and was approved by the ethics committee of the hospital.

Exclusion Criteria:

* (1) Uncontrolled arrhythmias combined with hemodynamic abnormalities.
* (2) COPD, pulmonary embolism, deep vein thrombosis, stroke and other factors affecting motor function.
* (3) Physical disability affecting safety and full participation in the experiment.
* (4) myocarditis, cardiomyopathy, liver and kidney insufficiency.
* (5) Aphasia, hearing impairment and other conditions affecting normal doctor-patient communication.

Conditions2

Coronary Heart DiseaseHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.